Quarterly report · Q3
6095.TEDINET S100OXHE
Period2021-10-01 → 2022-06-30
Filed2022-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.4bn | 2021-10-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥7.4bn | 2020-10-01 → 2021-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.5bn | 2020-10-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥907m | 2021-10-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥1.4bn | 2020-10-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥943m | 2021-10-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.8bn | 2020-10-01 → 2021-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2020-10-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥943m | 2021-10-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.4bn | 2020-10-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥655m | 2021-10-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.3bn | 2020-10-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥943m | 2020-10-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥651m | 2021-10-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥969m | 2020-10-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥9.2bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥8.5bn | at 2021-09-30 | Cons. | Assets |
| Total assets | ¥8.0bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥1.6bn | at 2021-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥7.7bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥7.0bn | at 2021-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.6bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.5bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.7bn | at 2021-09-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥30.33 | 2021-10-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.59 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.07 | 2020-10-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.82 | 2020-10-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.02 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥28.76 | 2021-10-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥56.25 | 2020-10-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥41.12 | 2020-10-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 80.6% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.5% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2021-10-01 → 2022-06-30 | −¥12m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-10-01 → 2022-06-30 | −¥12m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-06-30 | −¥518m |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue intersegment | 2021-10-01 → 2022-06-30 | ¥8m |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | segment profit | 2021-10-01 → 2022-06-30 | ¥1.3bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue intersegment | 2021-10-01 → 2022-06-30 | ¥4m |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | segment profit | 2021-10-01 → 2022-06-30 | ¥100m |
| —segment total | revenue | 2021-10-01 → 2022-06-30 | ¥6.5bn |
| —segment total | revenue external | 2021-10-01 → 2022-06-30 | ¥6.4bn |
| —segment total | revenue intersegment | 2021-10-01 → 2022-06-30 | ¥12m |
| —segment total | segment profit | 2021-10-01 → 2022-06-30 | ¥1.4bn |
| Reconciling Itemsreconciling | revenue | 2020-10-01 → 2021-06-30 | −¥6m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-10-01 → 2021-06-30 | −¥6m |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-06-30 | −¥357m |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥4.3bn |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥4.3bn |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue intersegment | 2020-10-01 → 2021-06-30 | ¥5m |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | segment profit | 2020-10-01 → 2021-06-30 | ¥1.5bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue intersegment | 2020-10-01 → 2021-06-30 | ¥396,000 |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | segment profit | 2020-10-01 → 2021-06-30 | ¥196m |
| —segment total | revenue | 2020-10-01 → 2021-06-30 | ¥5.5bn |
| —segment total | revenue external | 2020-10-01 → 2021-06-30 | ¥5.5bn |
| —segment total | revenue intersegment | 2020-10-01 → 2021-06-30 | ¥6m |
| —segment total | segment profit | 2020-10-01 → 2021-06-30 | ¥1.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 329
| Item | Context | Value | Unit |
|---|---|---|---|
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 943008000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 650593000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 25679000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | -3207000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E30650-000DoctorPlatFormReportableSegmentMember | 4271600000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E30650-000HealthcareSolutionReportableSegmentMember | 1231606000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 5503206000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | Prior1YTDDuration | 5503206000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E30650-000DoctorPlatFormReportableSegmentMember | 5128000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E30650-000HealthcareSolutionReportableSegmentMember | 396000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 5525000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -5525000 | JPY |
| Transactions with other segments | Prior1YTDDuration | - | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E30650-000DoctorPlatFormReportableSegmentMember | 4276728000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E30650-000HealthcareSolutionReportableSegmentMember | 1232003000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 5508731000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -5525000 | JPY |
| Net sales | Prior1YTDDuration | 5503206000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E30650-000DoctorPlatFormReportableSegmentMember | 1536072000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E30650-000HealthcareSolutionReportableSegmentMember | 196065000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 1732138000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -356587000 | JPY |
| Operating income | Prior1YTDDuration | 1375550000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E30650-000DoctorPlatFormReportableSegmentMember | 4902182000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E30650-000HealthcareSolutionReportableSegmentMember | 1541138000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 6443320000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | CurrentYTDDuration | 6443320000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E30650-000DoctorPlatFormReportableSegmentMember | 7881000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E30650-000HealthcareSolutionReportableSegmentMember | 4088000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 11969000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -11969000 | JPY |
| Transactions with other segments | CurrentYTDDuration | - | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E30650-000DoctorPlatFormReportableSegmentMember | 4910063000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E30650-000HealthcareSolutionReportableSegmentMember | 1545226000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 6455290000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -11969000 | JPY |
| Net sales | CurrentYTDDuration | 6443320000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E30650-000DoctorPlatFormReportableSegmentMember | 1324753000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E30650-000HealthcareSolutionReportableSegmentMember | 100300000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 1425054000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -517649000 | JPY |
| Operating income | CurrentYTDDuration | 907405000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の4の7第1項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-08-09 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第18期第3四半期(自 2022年4月1日 至 2022年6月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)メドピア株式会社 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |